Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair
Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution(R) System, a medical d…
Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution(R) System, a medical d…
Interim results from a breast reconstruction trial show stem and regenerative cellenriched fat grafting resulted in a hi…
Cytori Therapeutics (NASDAQ:CYTX) today received U.S. Patent No. 7,651,684 (the '684 patent) which covers the Company's…
Results from Cytori Therapeutics' (NASDAQ: CYTX) preclinical fat grafting study have been published in the February issu…